TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Polypeptide Laboratories Holding (PPL) AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
156,255
|
119,067
|
87,238 |
Financial expenses |
11,306
|
3,916
|
1,694 |
Earnings before taxes |
-29,931
|
-19,028
|
-4,572 |
EBITDA |
-51,465
|
-15,074
|
-1,773 |
Total assets |
395,228
|
269,039
|
198,046 |
Current assets |
134,866
|
52,178
|
41,874 |
Current liabilities |
118,001
|
76,378
|
81,213 |
Equity capital |
37,341
|
49,217
|
48,869 |
- share capital |
18
![]() |
18
![]() |
18 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
9.4%
|
18.3%
|
24.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
-19.2%
|
-16.0%
|
-5.2% |
Return on assets (ROA) |
-4.7%
|
-5.6%
|
-1.5% |
Current ratio |
114.3%
|
68.3%
|
51.6% |
Return on equity (ROE) |
-80.2%
|
-38.7%
|
-9.4% |
Change turnover |
36,841
|
38,896
|
17,886 |
Change turnover % |
31%
|
49%
|
26% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.